Skip to main content
. 2015 Aug 20;128(16):2147–2153. doi: 10.4103/0366-6999.162498

Figure 1.

Figure 1

Flow diagram of a study investigating the effects of warfarin on patients with pulmonary embolism complicated by obstructive sleep apnea hypopnea syndrome (OSAHS) versus those without OSAHS. Finished: Patients finished the antithrombotic treatment and follow-up with no adverse events during 18 months.